1.
Blauvelt A, Stein Gold L, Gooderham M, Strober B, Pinter A, Carrascosa J-M, Gisondi P, Bleier J, Madden C, Deherder D, Gomez NN, Warren RB. Bimekizumab efficacy and safety through two years in patients with moderate psoriasis: Analysis of pooled data from five phase 3/3b clinical trials. J of Skin [Internet]. 2022Nov.16 [cited 2024Jul.19];6(6):s67. Available from: https://jofskin.org/index.php/skin/article/view/1822